Author: pft3d

Biomaterials for minimally invasive therapeutics Co-Director, Institute for Minimally Invasive Therapeutics, David Geffen School of Medicine, University of California – Los Angeles Dr Nureddin Ashammakhi is working on translational tissue engineering and regenerative therapy, with experience in bioabsorbable polymeric biomaterials,...

Building a cell therapy company in aesthetics and orthopedics President & CEO, RepliCel Life Sciences, Inc. Lee is an enthusiastic executive in the cell therapy industry. Lee launched his career in the business side of the science sector at Malachite...

Panellist Partner, Intellectual Property & Technology Squire Patton Boggs Todd Lorenz is a Partner in Squire Patton Boggs Intellectual Property & Technology practice.  He advises emerging and established life science companies on all aspects of domestic and international patent procurement...

Panellist Surgeon, Artist, Author, Entrepreneur, OrthoSynthesis Inc. Dr. Faisal Mirza is a Board Certified Orthopaedic Surgeon in Silicon Valley engaged in a boutique clinical practice. Dr. Mirza completed his medical and surgical training in at the University of Western Ontario and...

Go with the bioprinting flow: microfluidics as a means to a human tissue design end VP, Tissue Engineering Aspect Biosystems Spiro is the VP of Tissue Engineering at Aspect and manages all partnered and internal tissue engineering programs. Spiro was...

Intra-tissue bioprinting: the future is now Associate Professor Department of Graduate Nursing Department of Materials Science and Engineering University of Texas at Arlington Dr. Varanasi received his doctorate from the University Of Florida Department Of Chemical Engineering in 2004 and...

Cell therapy for diabetes - a role for bioprinting? Professor, Cellular & Physiological Sciences and Surgery, University of British Columbia, Diabetes Research Group Leader, School of Biomedical Engineering, Life Sciences Institute Dr. Kieffer’s laboratory is focused on the development of...